GHRP-2 is a synthetic growth hormone secretagogue investigated as a probe of GH release, appetite, and the interaction between ghrelin and GHRH signaling.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Ghrelin-receptor agonist
Growth hormone-releasing peptide-2 is a small synthetic peptide commonly called GHRP-2. Its research lineage is distinct from GHRH-derived molecules such as sermorelin. Papers describing GHRP-2 should also be separated from studies of GHRP-6, hexarelin, or other secretagogues, because shared receptor activity does not guarantee identical endocrine profiles.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
GHRP-2 activates the growth hormone secretagogue receptor, the receptor used by ghrelin. This connects pituitary GH secretion with appetite-related signaling. The response also depends on the surrounding hypothalamic and pituitary system; experiments involving GHRH combinations probe that interaction rather than replacing it with a single isolated pathway.
A small crossover experiment in healthy lean men measured greater food intake and higher GH after GHRP-2 than after saline. The study established an acute physiological response, without testing sustained changes in body weight or nutritional status. [1]
A subsequent controlled study included lean and obese participants. Both groups showed food-intake and GH responses, illustrating that an appetite signal can remain experimentally responsive despite differences in adiposity. This was not a weight-management efficacy trial. [2]
A pediatric physiology study compared GHRP-2, GHRH(1–29), and their combination in children with different growth disorders. Variable responses emphasize the role of underlying endocrine function and the distinction between a stimulation test and a lasting growth outcome. [3]
Study topics describe the cited models, not established benefits of this catalog material.
Direct human evidence supports measurable acute effects on appetite and GH secretion under controlled conditions. The cited studies involve limited samples, selected participants, and specific study preparations. They do not establish durable changes in muscle, fat, recovery, or wellbeing in a general population.
An increase in a circulating hormone is not proof of a beneficial clinical outcome. Nutritional state, pituitary function, and other hormonal responses can alter interpretation. The references should not be used to infer WYZ Labs batch identity, selectivity, purity, or suitability for human use.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Acute crossover physiology experiment in seven lean men.
Controlled comparison in lean and obese participants; acute appetite and GH endpoints.
Acute stimulation study; distinguishes GHRP-2 from GHRH and does not establish long-term outcomes.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
